Oslo, Norway

Lars Orning




Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1998-2014

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Lars Orning: Innovator in Cobalamin Assay Technology

Introduction

Lars Orning is a prominent inventor based in Oslo, Norway, with a noteworthy portfolio of seven patents. His innovative contributions primarily focus on advancements in the field of cobalamin assays, showcasing his expertise in this critical area of research.

Latest Patents

Among Lars Orning's latest patents is a unique cobalamin assay, which provides a specific binding partner for holoTC (total cobalamin) that demonstrates a specificity for holoTC over apoTC of at least 40-fold. This groundbreaking invention outlines an assay method that involves contacting a sample with the specific binding partner for holoTC and subsequently detecting the formed conjugates. This innovation significantly enhances the accuracy of cobalamin level assessments in various samples.

Career Highlights

Throughout his career, Lars has made significant strides in the medical and biotechnological fields, particularly while working at companies such as Nycomed Imaging AS and Axis-Shield ASA. His roles at these organizations have allowed him to develop and refine his inventions, contributing to advancements in diagnostic technologies.

Collaborations

Lars Orning has collaborated with esteemed professionals, including Peter Fischer and Kjell Steinar Sakariassen, enhancing his work with diverse perspectives and expertise in the field. Their collaboration has undoubtedly played a role in the successful development of his patented technologies.

Conclusion

Lars Orning's contributions to cobalamin assay technology reflect his innovative spirit and dedication to improving diagnostic processes. With seven patents to his name and a solid foundation in both collaboration and professional practice, he continues to be an influential figure in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…